128 related articles for article (PubMed ID: 9973758)
1. A role for dopexamine hydrochloride in septic shock.
Murphy R
Ir Med J; 1998; 91(5):180. PubMed ID: 9973758
[No Abstract] [Full Text] [Related]
2. Meningococcal septic shock: is insulin lifesaving in children?
Mormile R; De Michele M
Int J Infect Dis; 2011 Jul; 15(7):e504. PubMed ID: 21530349
[No Abstract] [Full Text] [Related]
3. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
[TBL] [Abstract][Full Text] [Related]
4. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
Schmoelz M; Schelling G; Dunker M; Irlbeck M
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
[TBL] [Abstract][Full Text] [Related]
5. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
Derkx B; Wittes J; McCloskey R
Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
[TBL] [Abstract][Full Text] [Related]
6. Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock.
Bjerre A; Brusletto B; Høiby EA; Kierulf P; Brandtzaeg P
Crit Care Med; 2004 Feb; 32(2):433-8. PubMed ID: 14758160
[TBL] [Abstract][Full Text] [Related]
7. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
[TBL] [Abstract][Full Text] [Related]
8. Continuous low-dose infusion of terlipressin as a rescue therapy in meningococcal septic shock.
Michel F; Thomachot L; David M; Nicaise C; Vialet R; Di Marco JN; Lagier P; Martin C
Am J Emerg Med; 2007 Sep; 25(7):863.e1-2. PubMed ID: 17870513
[No Abstract] [Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Sprong T; Pickkers P; Geurts-Moespot A; van der Ven-Jongekrijg J; Neeleman C; Knaup M; Leroy D; Calandra T; van der Meer JW; Sweep F; van Deuren M
Shock; 2007 May; 27(5):482-7. PubMed ID: 17438452
[TBL] [Abstract][Full Text] [Related]
10. Survivors of septic shock caused by Neisseria meningitidis in childhood: psychosocial outcomes in young adulthood.
Vermunt LC; Buysse CM; Joosten KF; Duivenvoorden HJ; Hazelzet JA; Verhulst FC; Utens EM
Pediatr Crit Care Med; 2011 Nov; 12(6):e302-9. PubMed ID: 21499180
[TBL] [Abstract][Full Text] [Related]
11. [Septic shock: hemodynamic effects of noradrenaline and a noradrenaline-dopexamine combination].
Nouira S; Dhainaut JF; Brunet F; Armaganidis A; Giraud T; Garrauste MT; Corsia G; Schremmer B; Monsallier JF
Ann Fr Anesth Reanim; 1989; 8 Suppl():R234. PubMed ID: 2604192
[No Abstract] [Full Text] [Related]
12. Should steroids be used in children with meningococcal shock?
Branco RG; Russell RR
Arch Dis Child; 2005 Nov; 90(11):1195-6. PubMed ID: 16243881
[No Abstract] [Full Text] [Related]
13. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
[TBL] [Abstract][Full Text] [Related]
14. Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
Zenz W; Muntean W; Zobel G; Grubbauer HM; Gallistl S
Thromb Haemost; 1995 Aug; 74(2):802-3. PubMed ID: 8585030
[No Abstract] [Full Text] [Related]
15. Acute meningococcaemia: recent advances in management (with particular reference to children).
Kennedy NJ; Duncan AW
Anaesth Intensive Care; 1996 Apr; 24(2):197-216. PubMed ID: 9133195
[No Abstract] [Full Text] [Related]
16. [A case of meningococcal sepsis].
Bonzano L; Colombino G; Petri G; Vittone L; Barbera C; Manzoni R
Minerva Med; 1990 Mar; 81(3 Suppl):49-51. PubMed ID: 2109279
[TBL] [Abstract][Full Text] [Related]
17. Inherited complement deficiency in children surviving fulminant meningococcal septic shock.
Derkx HH; Kuijper EJ; Fijen CA; Jak M; Dankert J; van Deventer SJ
Eur J Pediatr; 1995 Sep; 154(9):735-8. PubMed ID: 8582425
[TBL] [Abstract][Full Text] [Related]
18. Acute myocardial infarction with normal coronary arteries during septic shock from Neisseria meningitidis.
Filippatos G; Kardara D; Paramithiotou E; Sioras E; Prekates A; Roussos C; Kardaras F
Intensive Care Med; 2000 Feb; 26(2):252. PubMed ID: 10784321
[No Abstract] [Full Text] [Related]
19. [Fibrinolyte therapy of septicemic shock in infancy and childhood].
Mitterstieler G; Kurz R; Waltl H; Berger H
Padiatr Padol; 1973; 8(2):225-31. PubMed ID: 4698436
[No Abstract] [Full Text] [Related]
20. Intracellular organisms in peripheral blood in a case of meningococcal septicaemia.
Scott MA; Gobert-Jones J
Clin Lab Haematol; 1990; 12(4):477-8. PubMed ID: 2127910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
